Literature DB >> 8561958

Drug-induced circling preference in rats. Correlation with monoamine levels.

S F Ali1, K J Kordsmeier, B Gough.   

Abstract

Drugs of abuse, such as phencyclidine (PCP), methamphetamine (METH), and cocaine (COC) are known to affect several behaviors in rats, such as motor activity, stereotypy, and circling. In this study, we evaluated whether these drugs produce circling preferences in the presence or absence of unilateral 6-hydroxydopamine (6-OHDA)-induced lesions of the caudate nucleus. Adult male CD rats were lesioned with 10 micrograms 6-OHDA/site. Animals were dosed with PCP (15 mg/kg, ip) its congener (+) MK-801 (0.15 mg/kp, ip), METH (2 mg/kg, ip) COC (60 mg/kp, ip), or apomorphine (0.2 mg/kg, ip). Circling preference was recorded in control and lesioned rats for 2 h before animals were sacrificed to determined monoamine levels by HPLC/EC. In control animals, administration of these drugs produced 60-70% left circling. In lesioned animals, these drugs produced 78-90% ipsilateral (toward the lesion) circling, except apomorphine, which produced 60-80% contralateral (away from the lesion) circling. Dopamine (DA) and its metabolites 3,4-dihydroxyphenylacetic acid (DOPAC) and homovanillic acid (HVA) concentrations significantly decreased ipsilaterally in lesioned caudate nucleus (CN) and substantia nigra (SN). However, no significant changes were observed in nucleus accumbens (NA) and olfactory tubercles (OT). These data demonstrate that drugs of abuse like PCP, its congener (+) MK-801, METH, and COC produce a greater preference to turn toward the left than the right, a finding similar to that found in human psychosis. Since 6-OHDA lesions enhanced the circling bias and depleted DA and its metabolites DOPAC and HVA, it also suggests that the dopaminergic system may be involved in the circling behavior.

Entities:  

Mesh:

Substances:

Year:  1995        PMID: 8561958     DOI: 10.1007/BF02740691

Source DB:  PubMed          Journal:  Mol Neurobiol        ISSN: 0893-7648            Impact factor:   5.590


  34 in total

1.  Beta-adrenergic blockers and intermittent claudication. Time for reappraisal.

Authors:  U Thadani; T L Whitsett
Journal:  Arch Intern Med       Date:  1991-09

Review 2.  Hyperactivity of the left striato-pallidal projection. Part I: Lower level theory.

Authors:  T S Early; M I Posner; E M Reiman; M E Raichle
Journal:  Psychiatr Dev       Date:  1989

3.  Effect of the dopamine D-1 antagonist SCH 23390 on rotational behaviour induced by apomorphine and pergolide in 6-hydroxy-dopamine denervated rats.

Authors:  M Herrera-Marschitz; U Ungerstedt
Journal:  Eur J Pharmacol       Date:  1985-03-12       Impact factor: 4.432

4.  Dopamine D1- and D2-receptor interaction in turning behaviour induced by dopamine agonists in 6-hydroxydopamine-lesioned rats.

Authors:  G Karlsson; A L Jaton; J M Vigouret
Journal:  Neurosci Lett       Date:  1988-05-16       Impact factor: 3.046

5.  Cocaine produces locomotor stimulation in SS but not LS mice: relationship to dopaminergic function.

Authors:  F R George; M C Ritz
Journal:  Psychopharmacology (Berl)       Date:  1990       Impact factor: 4.530

6.  Phencyclidine and (+)-MK-801-induced circling preference: correlation with monoamine levels in striatum of the rat brain.

Authors:  S F Ali; G D Newport; H S Bracha
Journal:  Neurotoxicol Teratol       Date:  1994 Jul-Aug       Impact factor: 3.763

7.  Acute and chronic behavioral interactions between phencyclidine (PCP) and amphetamine: evidence for a dopaminergic role in some PCP-induced behaviors.

Authors:  B D Greenberg; D S Segal
Journal:  Pharmacol Biochem Behav       Date:  1985-07       Impact factor: 3.533

8.  Age-related susceptibility to MPTP-induced neurotoxicity in mice.

Authors:  S F Ali; S N David; G D Newport
Journal:  Neurotoxicology       Date:  1993       Impact factor: 4.294

Review 9.  Recent advances in the phencyclidine model of schizophrenia.

Authors:  D C Javitt; S R Zukin
Journal:  Am J Psychiatry       Date:  1991-10       Impact factor: 18.112

10.  Turning behaviour as an index of the action of amphetamines and ephedrines on central dopamine-containing neurones.

Authors:  J E Christie; T J Crow
Journal:  Br J Pharmacol       Date:  1971-11       Impact factor: 8.739

View more
  5 in total

1.  Methamphetamine Induces Dopamine Release in the Nucleus Accumbens Through a Sigma Receptor-Mediated Pathway.

Authors:  David M Hedges; J Daniel Obray; Jordan T Yorgason; Eun Young Jang; Vajira K Weerasekara; Joachim D Uys; Frederick P Bellinger; Scott C Steffensen
Journal:  Neuropsychopharmacology       Date:  2017-11-29       Impact factor: 7.853

2.  Effects of hallucinogenic agents mescaline and phencyclidine on zebrafish behavior and physiology.

Authors:  Evan J Kyzar; Christopher Collins; Siddharth Gaikwad; Jeremy Green; Andrew Roth; Louie Monnig; Mohamed El-Ounsi; Ari Davis; Andrew Freeman; Nicholas Capezio; Adam Michael Stewart; Allan V Kalueff
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2012-01-09       Impact factor: 5.067

Review 3.  Methamphetamine, neurotransmitters and neurodevelopment.

Authors:  B Čechová; R Šlamberová
Journal:  Physiol Res       Date:  2021-12-31       Impact factor: 1.881

4.  Dopamine transporter inhibition is required for cocaine-induced stereotypy.

Authors:  Michael R Tilley; Howard H Gu
Journal:  Neuroreport       Date:  2008-07-16       Impact factor: 1.837

5.  Methamphetamine increases dopamine release in the nucleus accumbens through calcium-dependent processes.

Authors:  Jordan T Yorgason; David M Hedges; J Daniel Obray; Eun Young Jang; Kyle B Bills; Mark Woodbury; Ben Williams; Mandy J Parsons; Marilou A Andres; Scott C Steffensen
Journal:  Psychopharmacology (Berl)       Date:  2020-01-21       Impact factor: 4.530

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.